These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21561063)

  • 1. Determinants of membrane activity from mutational analysis of the HIV fusion peptide.
    Torres O; Bong D
    Biochemistry; 2011 Jun; 50(23):5195-207. PubMed ID: 21561063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues.
    Delahunty MD; Rhee I; Freed EO; Bonifacino JS
    Virology; 1996 Apr; 218(1):94-102. PubMed ID: 8615045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
    Joshi SB; Dutch RE; Lamb RA
    Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
    Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
    Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
    Ghosh JK; Shai Y
    J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
    Wexler-Cohen Y; Sackett K; Shai Y
    Biochemistry; 2005 Apr; 44(15):5853-61. PubMed ID: 15823044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
    Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study.
    Sackett K; Shai Y
    J Mol Biol; 2005 Jul; 350(4):790-805. PubMed ID: 15964015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunogenic CBD1 peptide corresponding to the caveolin-1 binding domain in HIV-1 envelope gp41 has the capacity to penetrate the cell membrane and bind caveolin-1.
    Benferhat R; Sanchez-Martinez S; Nieva JL; Briand JP; Hovanessian AG
    Mol Immunol; 2008 Apr; 45(7):1963-75. PubMed ID: 18054388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-induced conformational change during the activation of HIV-1 gp41.
    Kliger Y; Peisajovich SG; Blumenthal R; Shai Y
    J Mol Biol; 2000 Aug; 301(4):905-14. PubMed ID: 10966795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
    Kanyalkar M; Srivastava S; Saran A; Coutinho E
    J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O; Sackett K; Shai Y
    J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.